These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16102557)

  • 1. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study.
    Warren MP; Miller KK; Olson WH; Grinspoon SK; Friedman AJ
    Contraception; 2005 Sep; 72(3):206-11. PubMed ID: 16102557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
    Grinspoon SK; Friedman AJ; Miller KK; Lippman J; Olson WH; Warren MP
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3651-6. PubMed ID: 12915650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study.
    Strokosch GR; Friedman AJ; Wu SC; Kamin M
    J Adolesc Health; 2006 Dec; 39(6):819-27. PubMed ID: 17116511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
    Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
    Creinin MD; Lippman JS; Eder SE; Godwin AJ; Olson W
    Contraception; 2002 Sep; 66(3):147-52. PubMed ID: 12384201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
    Vescovi JD; VanHeest JL; De Souza MJ
    Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
    Sulak P; Lippman J; Siu C; Massaro J; Godwin A
    Contraception; 1999 Mar; 59(3):161-6. PubMed ID: 10382078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Extended 30 μg Ethinyl Estradiol with Continuous Low-Dose Ethinyl Estradiol and Cyclic 20 μg Ethinyl Estradiol Oral Contraception on Adolescent Bone Density: A Randomized Trial.
    Gersten J; Hsieh J; Weiss H; Ricciotti NA
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):635-642. PubMed ID: 27287084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives.
    Castelo-Branco C; Vicente JJ; Pons F; Martínez de Osaba MJ; Casals E; Vanrell JA
    J Reprod Med; 2001 Oct; 46(10):875-9. PubMed ID: 11725730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.
    Davis A; Godwin A; Lippman J; Olson W; Kafrissen M
    Obstet Gynecol; 2000 Dec; 96(6):913-20. PubMed ID: 11084177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
    Thorneycroft lH; Gollnick H; Schellschmidt I
    Cutis; 2004 Aug; 74(2):123-30. PubMed ID: 15379365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Hampton RM; Zhang HF; Barnowski C; Wan GJ
    Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
    Hammond GL; Abrams LS; Creasy GW; Natarajan J; Allen JG; Siiteri PK
    Contraception; 2003 Feb; 67(2):93-9. PubMed ID: 12586319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
    Hampton RM; Fisher AC; Pagano S; LaGuardia KD
    Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol.
    Sørdal T; Grob P; Verhoeven C
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1279-85. PubMed ID: 22762147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months.
    Hergenroeder AC; Smith EO; Shypailo R; Jones LA; Klish WJ; Ellis K
    Am J Obstet Gynecol; 1997 May; 176(5):1017-25. PubMed ID: 9166162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
    Tantbirojn P; Taneepanichskul S
    Contraception; 2002 Dec; 66(6):401-5. PubMed ID: 12499031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.